[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Outbreak-Global Beta-Thal Disease Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

December 2020 | 123 pages | ID: CC9A4E41951EEN
Maia Research

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Beta-Thal Disease market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Beta-Thal Disease industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Beta-Thal Disease market can be split based on product types, major applications, and important countries as follows:

Key players in the global Beta-Thal Disease market covered in Chapter 12:
Gamida Cell
bluebird bio, Inc.
IONIS Pharmaceuticals
Celgene Corporation
Acceleron Pharma, Inc.
La Jolla Pharmaceutical Company
Kiadis Pharma
Incyte Corporation
GlaxoSmithKline plc

In Chapter 4 and 14.1, on the basis of types, the Beta-Thal Disease market from 2015 to 2025 is primarily split into:
Iron Chelating Drugs
Gene Therapy

In Chapter 5 and 14.2, on the basis of applications, the Beta-Thal Disease market from 2015 to 2025 covers:
Hospitals
Biotechnological Laboratories
Diagnostic Laboratories

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 BETA-THAL DISEASE INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Beta-Thal Disease
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Beta-Thal Disease industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Beta-Thal Disease Market Size, 2015 – 2020
  2.1.2 Global Beta-Thal Disease Market Size by Type, 2015 – 2020
  2.1.3 Global Beta-Thal Disease Market Size by Application, 2015 – 2020
  2.1.4 Global Beta-Thal Disease Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Beta-Thal Disease Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Beta-Thal Disease Analysis
3.2 Major Players of Beta-Thal Disease
3.3 Beta-Thal Disease Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Beta-Thal Disease
  3.3.3 Labor Cost of Beta-Thal Disease
3.4 Market Distributors of Beta-Thal Disease
3.5 Major Downstream Buyers of Beta-Thal Disease Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL BETA-THAL DISEASE MARKET, BY TYPE

4.1 Global Beta-Thal Disease Value and Market Share by Type (2015-2020)
4.2 Global Beta-Thal Disease Production and Market Share by Type (2015-2020)
4.3 Global Beta-Thal Disease Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Beta-Thal Disease Value and Growth Rate of Iron Chelating Drugs
  4.3.2 Global Beta-Thal Disease Value and Growth Rate of Gene Therapy
4.4 Global Beta-Thal Disease Price Analysis by Type (2015-2020)

5 BETA-THAL DISEASE MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Beta-Thal Disease Consumption and Market Share by Application (2015-2020)
5.3 Global Beta-Thal Disease Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Beta-Thal Disease Consumption and Growth Rate of Hospitals (2015-2020)
  5.3.2 Global Beta-Thal Disease Consumption and Growth Rate of Biotechnological Laboratories (2015-2020)
  5.3.3 Global Beta-Thal Disease Consumption and Growth Rate of Diagnostic Laboratories (2015-2020)

6 GLOBAL BETA-THAL DISEASE MARKET ANALYSIS BY REGIONS

6.1 Global Beta-Thal Disease Sales, Revenue and Market Share by Regions
  6.1.1 Global Beta-Thal Disease Sales by Regions (2015-2020)
  6.1.2 Global Beta-Thal Disease Revenue by Regions (2015-2020)
6.2 North America Beta-Thal Disease Sales and Growth Rate (2015-2020)
6.3 Europe Beta-Thal Disease Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Beta-Thal Disease Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Beta-Thal Disease Sales and Growth Rate (2015-2020)
6.6 South America Beta-Thal Disease Sales and Growth Rate (2015-2020)

7 NORTH AMERICA BETA-THAL DISEASE MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Beta-Thal Disease Sales, Revenue and Market Share by Countries
  7.2.1 North America Beta-Thal Disease Sales by Countries (2015-2020)
  7.2.2 North America Beta-Thal Disease Revenue by Countries (2015-2020)
7.3 United States Beta-Thal Disease Sales and Growth Rate (2015-2020)
7.4 Canada Beta-Thal Disease Sales and Growth Rate (2015-2020)
7.5 Mexico Beta-Thal Disease Sales and Growth Rate (2015-2020)

8 EUROPE BETA-THAL DISEASE MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Beta-Thal Disease Sales, Revenue and Market Share by Countries
  8.2.1 Europe Beta-Thal Disease Sales by Countries (2015-2020)
  8.2.2 Europe Beta-Thal Disease Revenue by Countries (2015-2020)
8.3 Germany Beta-Thal Disease Sales and Growth Rate (2015-2020)
8.4 UK Beta-Thal Disease Sales and Growth Rate (2015-2020)
8.5 France Beta-Thal Disease Sales and Growth Rate (2015-2020)
8.6 Italy Beta-Thal Disease Sales and Growth Rate (2015-2020)
8.7 Spain Beta-Thal Disease Sales and Growth Rate (2015-2020)
8.8 Russia Beta-Thal Disease Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC BETA-THAL DISEASE MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Beta-Thal Disease Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Beta-Thal Disease Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Beta-Thal Disease Revenue by Countries (2015-2020)
9.3 China Beta-Thal Disease Sales and Growth Rate (2015-2020)
9.4 Japan Beta-Thal Disease Sales and Growth Rate (2015-2020)
9.5 South Korea Beta-Thal Disease Sales and Growth Rate (2015-2020)
9.6 India Beta-Thal Disease Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Beta-Thal Disease Sales and Growth Rate (2015-2020)
9.8 Australia Beta-Thal Disease Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA BETA-THAL DISEASE MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Beta-Thal Disease Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Beta-Thal Disease Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Beta-Thal Disease Revenue by Countries (2015-2020)
10.3 Saudi Arabia Beta-Thal Disease Sales and Growth Rate (2015-2020)
10.4 UAE Beta-Thal Disease Sales and Growth Rate (2015-2020)
10.5 Egypt Beta-Thal Disease Sales and Growth Rate (2015-2020)
10.6 Nigeria Beta-Thal Disease Sales and Growth Rate (2015-2020)
10.7 South Africa Beta-Thal Disease Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA BETA-THAL DISEASE MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Beta-Thal Disease Sales, Revenue and Market Share by Countries
  11.2.1 South America Beta-Thal Disease Sales by Countries (2015-2020)
  11.2.2 South America Beta-Thal Disease Revenue by Countries (2015-2020)
11.3 Brazil Beta-Thal Disease Sales and Growth Rate (2015-2020)
11.4 Argentina Beta-Thal Disease Sales and Growth Rate (2015-2020)
11.5 Columbia Beta-Thal Disease Sales and Growth Rate (2015-2020)
11.6 Chile Beta-Thal Disease Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Gamida Cell
  12.1.1 Gamida Cell Basic Information
  12.1.2 Beta-Thal Disease Product Introduction
  12.1.3 Gamida Cell Production, Value, Price, Gross Margin 2015-2020
12.2 bluebird bio, Inc.
  12.2.1 bluebird bio, Inc. Basic Information
  12.2.2 Beta-Thal Disease Product Introduction
  12.2.3 bluebird bio, Inc. Production, Value, Price, Gross Margin 2015-2020
12.3 IONIS Pharmaceuticals
  12.3.1 IONIS Pharmaceuticals Basic Information
  12.3.2 Beta-Thal Disease Product Introduction
  12.3.3 IONIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.4 Celgene Corporation
  12.4.1 Celgene Corporation Basic Information
  12.4.2 Beta-Thal Disease Product Introduction
  12.4.3 Celgene Corporation Production, Value, Price, Gross Margin 2015-2020
12.5 Acceleron Pharma, Inc.
  12.5.1 Acceleron Pharma, Inc. Basic Information
  12.5.2 Beta-Thal Disease Product Introduction
  12.5.3 Acceleron Pharma, Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 La Jolla Pharmaceutical Company
  12.6.1 La Jolla Pharmaceutical Company Basic Information
  12.6.2 Beta-Thal Disease Product Introduction
  12.6.3 La Jolla Pharmaceutical Company Production, Value, Price, Gross Margin 2015-2020
12.7 Kiadis Pharma
  12.7.1 Kiadis Pharma Basic Information
  12.7.2 Beta-Thal Disease Product Introduction
  12.7.3 Kiadis Pharma Production, Value, Price, Gross Margin 2015-2020
12.8 Incyte Corporation
  12.8.1 Incyte Corporation Basic Information
  12.8.2 Beta-Thal Disease Product Introduction
  12.8.3 Incyte Corporation Production, Value, Price, Gross Margin 2015-2020
12.9 GlaxoSmithKline plc
  12.9.1 GlaxoSmithKline plc Basic Information
  12.9.2 Beta-Thal Disease Product Introduction
  12.9.3 GlaxoSmithKline plc Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL BETA-THAL DISEASE MARKET FORECAST

14.1 Global Beta-Thal Disease Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Iron Chelating Drugs Market Value and Volume Forecast (2020-2025)
  14.1.2 Gene Therapy Market Value and Volume Forecast (2020-2025)
14.2 Global Beta-Thal Disease Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
  14.2.2 Biotechnological Laboratories Market Value and Volume Forecast (2020-2025)
  14.2.3 Diagnostic Laboratories Market Value and Volume Forecast (2020-2025)
14.3 Beta-Thal Disease Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
LIST OF TABLES AND FIGURES

Figure Product Picture of Beta-Thal Disease
Table Product Specification of Beta-Thal Disease
Table Beta-Thal Disease Key Market Segments
Table Key Players Beta-Thal Disease Covered
Figure Global Beta-Thal Disease Market Size, 2015 – 2025
Table Different Types of Beta-Thal Disease
Figure Global Beta-Thal Disease Value ($) Segment by Type from 2015-2020
Figure Global Beta-Thal Disease Market Share by Types in 2019
Table Different Applications of Beta-Thal Disease
Figure Global Beta-Thal Disease Value ($) Segment by Applications from 2015-2020
Figure Global Beta-Thal Disease Market Share by Applications in 2019
Figure Global Beta-Thal Disease Market Share by Regions in 2019
Figure North America Beta-Thal Disease Production Value ($) and Growth Rate (2015-2020)
Figure Europe Beta-Thal Disease Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Beta-Thal Disease Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Beta-Thal Disease Production Value ($) and Growth Rate (2015-2020)
Figure South America Beta-Thal Disease Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Beta-Thal Disease
Table Upstream Raw Material Suppliers of Beta-Thal Disease with Contact Information
Table Major Players Headquarters, and Service Area of Beta-Thal Disease
Figure Major Players Production Value Market Share of Beta-Thal Disease in 2019
Table Major Players Beta-Thal Disease Product Types in 2019
Figure Production Process of Beta-Thal Disease
Figure Manufacturing Cost Structure of Beta-Thal Disease
Figure Channel Status of Beta-Thal Disease
Table Major Distributors of Beta-Thal Disease with Contact Information
Table Major Downstream Buyers of Beta-Thal Disease with Contact Information
Table Global Beta-Thal Disease Value ($) by Type (2015-2020)
Table Global Beta-Thal Disease Value Share by Type (2015-2020)
Figure Global Beta-Thal Disease Value Share by Type (2015-2020)
Table Global Beta-Thal Disease Production by Type (2015-2020)
Table Global Beta-Thal Disease Production Share by Type (2015-2020)
Figure Global Beta-Thal Disease Production Share by Type (2015-2020)
Figure Global Beta-Thal Disease Value ($) and Growth Rate of Iron Chelating Drugs (2015-2020)
Figure Global Beta-Thal Disease Value ($) and Growth Rate of Gene Therapy (2015-2020)
Figure Global Beta-Thal Disease Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Beta-Thal Disease Consumption by Application (2015-2020)
Table Global Beta-Thal Disease Consumption Market Share by Application (2015-2020)
Figure Global Beta-Thal Disease Consumption Market Share by Application (2015-2020)
Figure Global Beta-Thal Disease Consumption and Growth Rate of Hospitals (2015-2020)
Figure Global Beta-Thal Disease Consumption and Growth Rate of Biotechnological Laboratories (2015-2020)
Figure Global Beta-Thal Disease Consumption and Growth Rate of Diagnostic Laboratories (2015-2020)
Figure Global Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Global Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table Global Beta-Thal Disease Sales by Regions (2015-2020)
Table Global Beta-Thal Disease Sales Market Share by Regions (2015-2020)
Table Global Beta-Thal Disease Revenue (M USD) by Regions (2015-2020)
Table Global Beta-Thal Disease Revenue Market Share by Regions (2015-2020)
Table Global Beta-Thal Disease Revenue Market Share by Regions in 2015
Table Global Beta-Thal Disease Revenue Market Share by Regions in 2019
Figure North America Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Europe Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure South America Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table North America Beta-Thal Disease Sales by Countries (2015-2020)
Table North America Beta-Thal Disease Sales Market Share by Countries (2015-2020)
Table North America Beta-Thal Disease Revenue (M USD) by Countries (2015-2020)
Table North America Beta-Thal Disease Revenue Market Share by Countries (2015-2020)
Figure United States Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Canada Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Mexico Beta-Thal Disease Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table Europe Beta-Thal Disease Sales by Countries (2015-2020)
Table Europe Beta-Thal Disease Sales Market Share by Countries (2015-2020)
Table Europe Beta-Thal Disease Revenue (M USD) by Countries (2015-2020)
Table Europe Beta-Thal Disease Revenue Market Share by Countries (2015-2020)
Figure Germany Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure UK Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure France Beta-Thal Disease Sales and Growth (2015-2020)
Figure Italy Beta-Thal Disease Sales and Growth (2015-2020)
Figure Spain Beta-Thal Disease Sales and Growth (2015-2020)
Figure Russia Beta-Thal Disease Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Beta-Thal Disease Sales by Countries (2015-2020)
Table Asia Pacific Beta-Thal Disease Sales Market Share by Countries (2015-2020)
Table Asia Pacific Beta-Thal Disease Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Beta-Thal Disease Revenue Market Share by Countries (2015-2020)
Figure China Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Japan Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure South Korea Beta-Thal Disease Sales and Growth (2015-2020)
Figure India Beta-Thal Disease Sales and Growth (2015-2020)
Figure Southeast Asia Beta-Thal Disease Sales and Growth (2015-2020)
Figure Australia Beta-Thal Disease Sales and Growth (2015-2020)
Figure Middle East Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table Middle East Beta-Thal Disease Sales by Countries (2015-2020)
Table Middle East and Africa Beta-Thal Disease Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Beta-Thal Disease Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Beta-Thal Disease Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure UAE Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Egypt Beta-Thal Disease Sales and Growth (2015-2020)
Figure Nigeria Beta-Thal Disease Sales and Growth (2015-2020)
Figure South Africa Beta-Thal Disease Sales and Growth (2015-2020)
Figure South America Beta-Thal Disease Revenue (M USD) and Growth (2015-2020)
Table South America Beta-Thal Disease Sales by Countries (2015-2020)
Table South America Beta-Thal Disease Sales Market Share by Countries (2015-2020)
Table South America Beta-Thal Disease Revenue (M USD) by Countries (2015-2020)
Table South America Beta-Thal Disease Revenue Market Share by Countries (2015-2020)
Figure Brazil Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Argentina Beta-Thal Disease Sales and Growth Rate (2015-2020)
Figure Columbia Beta-Thal Disease Sales and Growth (2015-2020)
Figure Chile Beta-Thal Disease Sales and Growth (2015-2020)
Figure Top 3 Market Share of Beta-Thal Disease Companies in 2019
Figure Top 6 Market Share of Beta-Thal Disease Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Gamida Cell Profile
Table Gamida Cell Product Introduction
Figure Gamida Cell Production and Growth Rate
Figure Gamida Cell Value ($) Market Share 2015-2020
Table bluebird bio, Inc. Profile
Table bluebird bio, Inc. Product Introduction
Figure bluebird bio, Inc. Production and Growth Rate
Figure bluebird bio, Inc. Value ($) Market Share 2015-2020
Table IONIS Pharmaceuticals Profile
Table IONIS Pharmaceuticals Product Introduction
Figure IONIS Pharmaceuticals Production and Growth Rate
Figure IONIS Pharmaceuticals Value ($) Market Share 2015-2020
Table Celgene Corporation Profile
Table Celgene Corporation Product Introduction
Figure Celgene Corporation Production and Growth Rate
Figure Celgene Corporation Value ($) Market Share 2015-2020
Table Acceleron Pharma, Inc. Profile
Table Acceleron Pharma, Inc. Product Introduction
Figure Acceleron Pharma, Inc. Production and Growth Rate
Figure Acceleron Pharma, Inc. Value ($) Market Share 2015-2020
Table La Jolla Pharmaceutical Company Profile
Table La Jolla Pharmaceutical Company Product Introduction
Figure La Jolla Pharmaceutical Company Production and Growth Rate
Figure La Jolla Pharmaceutical Company Value ($) Market Share 2015-2020
Table Kiadis Pharma Profile
Table Kiadis Pharma Product Introduction
Figure Kiadis Pharma Production and Growth Rate
Figure Kiadis Pharma Value ($) Market Share 2015-2020
Table Incyte Corporation Profile
Table Incyte Corporation Product Introduction
Figure Incyte Corporation Production and Growth Rate
Figure Incyte Corporation Value ($) Market Share 2015-2020
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Product Introduction
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2015-2020
Table Market Driving Factors of Beta-Thal Disease
Table Merger, Acquisition and New Investment
Table Global Beta-Thal Disease Market Value ($) Forecast, by Type
Table Global Beta-Thal Disease Market Volume Forecast, by Type
Figure Global Beta-Thal Disease Market Value ($) and Growth Rate Forecast of Iron Chelating Drugs (2020-2025)
Figure Global Beta-Thal Disease Market Volume ($) and Growth Rate Forecast of Iron Chelating Drugs (2020-2025)
Figure Global Beta-Thal Disease Market Value ($) and Growth Rate Forecast of Gene Therapy (2020-2025)
Figure Global Beta-Thal Disease Market Volume ($) and Growth Rate Forecast of Gene Therapy (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Biotechnological Laboratories (2020-2025)
Figure Market Volume and Growth Rate Forecast of Biotechnological Laboratories (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Diagnostic Laboratories (2020-2025)
Figure Market Volume and Growth Rate Forecast of Diagnostic Laboratories (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery


More Publications